Continuous Glucose Monitoring (CGM) Devices Market to Reach US$ 10.72 Billion by 2033 Driven by Rising Diabetes Prevalence, Wearable Health Tech Adoption, and Advancements in Real-Time Glucose Monitoring Solutions

The Continuous Glucose Monitoring (CGM) Devices Market reached US$ 6.06 billion in 2025 and is expected to reach US$ 10.72 billion by 2033, growing at a CAGR of 8.1% during the forecast period 2026-2033.

Growth is driven by the rising prevalence of diabetes and increasing demand for real-time glucose monitoring solutions that improve disease management and patient outcomes. CGM devices enable continuous tracking of glucose levels, helping patients and healthcare providers make timely and informed treatment decisions. Additionally, growing adoption of wearable medical devices, integration with smartphones and insulin delivery systems, and increasing awareness of preventive healthcare are accelerating market expansion. Advancements in sensor technology, data analytics, and minimally invasive monitoring solutions, along with expanding access to digital health platforms, are further fueling the global growth of the CGM devices market.

Download your exclusive sample report(corporate email gets priority access): https://www.datamintelligence.com/download-sample/continuous-glucose-monitoring-devices-market?praneetha

✦ Continuous Glucose Monitoring (CGM) Devices Market: Competitive Intelligence
The major global players in the market include Abbott, Dexcom, Inc., Medtronic Plc, Ascensia Diabetes Care Holdings AG, F. Hoffmann-La Roche Ltd., iHealth Labs Inc., Ypsomed AG, Medtrum Technologies Inc., Menarini Diagnostics S.r.l., Nemaura Medical Inc., Senseonics Holdings, Inc., Glucovation, Inc., Afon Technology, and Signos Inc., among others.

The Continuous Glucose Monitoring (CGM) Devices Market is driven by leading medical device and diabetes care companies such as Abbott, Dexcom, and Medtronic, which offer advanced CGM systems that provide real-time glucose monitoring, trend analysis, and improved diabetes management. These devices help patients and healthcare providers make informed decisions, reduce complications, and enhance quality of life.

These companies' complementary strengths including Abbott and Dexcom's leadership in sensor based CGM technologies, Medtronic's integration with insulin delivery systems, and Roche and Ascensia's strong diabetes care portfolios are strengthening competitive positioning. Emerging players like Senseonics and Nemaura are focusing on innovative solutions such as implantable and non-invasive glucose monitoring technologies. Continuous investments in sensor accuracy, wearable device miniaturization, smartphone integration, and AI-driven glucose analytics are driving market growth amid increasing diabetes prevalence and rising demand for personalized and continuous health monitoring solutions.

Ready to scale in this Market ? Connect with the right partners and unlock new growth opportunities :- https://www.datamintelligence.com/partner-identification-enquiry//continuous-glucose-monitoring-devices-market?praneetha

✦ New Product Launches
Dexcom, Inc.
Dexcom expanded its CGM portfolio with next-generation continuous glucose monitoring systems featuring improved accuracy and real-time data sharing capabilities. The devices offer longer wear duration and seamless smartphone integration. These innovations enhance diabetes management and patient convenience.

Abbott Laboratories
Abbott introduced advanced FreeStyle Libre systems with enhanced sensor performance and user-friendly features. The products provide continuous glucose readings without the need for frequent finger pricks. These developments improve accessibility and adoption among diabetic patients.

✦ R&D Developments
Medtronic plc
Medtronic continued R&D in CGM technologies, focusing on closed loop insulin delivery systems and improved sensor accuracy. The company is developing integrated solutions for automated diabetes management. These advancements support better glycemic control and patient outcomes.

Senseonics Holdings, Inc.
Senseonics advanced research in implantable CGM systems with extended sensor lifespan and continuous monitoring capabilities. The company is focusing on long-term wearable solutions. These developments enhance patient comfort and reduce maintenance frequency.

✦ Technological Advancements
Real-Time Monitoring & Smartphone Integration
The market is witnessing strong advancements in CGM devices that provide real-time glucose data through mobile apps and cloud platforms. These systems enable remote monitoring and data sharing. This improves patient engagement and clinical decision making.

Closed-Loop Systems & AI Integration
Technological progress is enabling integration of CGM devices with insulin pumps and AI-driven algorithms for automated insulin delivery. These solutions optimize glucose control and reduce manual intervention. This supports the development of artificial pancreas systems.

✦ M&A / Strategic Developments
Roche Diabetes Care
Roche continued strategic expansions in diabetes management solutions, including CGM technologies. The company is focusing on integrating digital health platforms with monitoring devices. These initiatives strengthen its position in the diabetes care market.

Ascensia Diabetes Care (PHC Holdings)
Ascensia pursued strategic developments in glucose monitoring through partnerships and product innovation. The company is focusing on expanding its CGM portfolio. This supports growth in advanced diabetes management solutions.

Request Custom Intelligence Report: https://www.datamintelligence.com/customize//continuous-glucose-monitoring-devices-market?praneetha

✦ Market Segmentation
By Component
The market is segmented into Sensors 55%, Transmitters 25%, and Receivers 20%, with sensors dominating due to their recurring usage and critical role in continuous glucose measurement.

By Connectivity
The market includes Bluetooth 75% and Wi-Fi 25%, with Bluetooth dominating due to its widespread integration with smartphones and wearable devices for real-time monitoring.

By Application
The market is segmented into Type 1 Diabetes 45%, Type 2 Diabetes 35%, Prediabetes 12%, and Gestational Diabetes 8%, with Type 1 diabetes dominating due to higher dependency on continuous glucose monitoring.

By End-User
The market includes Homecare Settings 40%, Hospitals & Clinics 35%, Diagnostic Centers 15%, and Others 10%, with homecare settings dominating due to increasing preference for remote monitoring and self-management.

✦ Regional Analysis
North America - 40% Share
North America leads with 40% share driven by high diabetes prevalence, advanced healthcare infrastructure, and strong adoption of wearable medical technologies.

Europe - 25% Share
Europe accounts for 25% share supported by favorable reimbursement policies and increasing awareness of diabetes management.

Asia-Pacific - 22% Share
Asia-Pacific holds 22% share due to rising diabetic population and improving healthcare access.

Purchase Corporate License | Market Intelligence:
https://www.datamintelligence.com/buy-now-page?report=continuous-glucose-monitoring-devices-market?praneetha

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Fabian
DataM Intelligence 4market Research LLP
6th Floor, M2 Tech Hub, DataM Intelligence 4market Research LLP, Lalitha Nagar, Habsiguda, Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
UK: +44 161-870-5507
Email: fabian@datamintelligence.com

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.